Format

Send to

Choose Destination
Chest. 1987 Oct;92(4):618-20.

A controlled trial of ambroxol in chronic bronchitis.

Author information

1
Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ontario, Canada.

Abstract

Ambroxol is a mucolytic agent which is widely used in chronic bronchitis in Europe. We conducted a double-blind randomized controlled trial of ambroxol vs matched placebo in 90 patients with chronic bronchitis and difficulty clearing secretions. It was concluded that there was no advantage to taking ambroxol.

PMID:
3308343
DOI:
10.1378/chest.92.4.618
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center